a group of seasoned biopharma entrepreneurs, executives, and scientists
with proven track records of success on a global scale
Laurie Gee is a creative business executive with over 25 years of experience in finance and business operations in various industries and company stages, including startups, publicly traded companies, and privately held organizations. In addition, Laurie has extensive M&A experience. Most recently Laurie spearheaded tax-free spinoffs of the therapeutic divisions for Crown Biosciences and Applied StemCell resulting in standalone therapeutic companies, Apollomics (Crown Biosciences) and Applied StemCell Therapeutics (Applied StemCell). Both Apollomics and Applied StemCell Therapeutics continue to further their drug discovery programs. Prior to joining Innoland Biosciences Inc., Laurie was the Chief Financial Officer at Epitomics. Epitomics was acquired by Abcam, subsequently she continued to play a leadership role in integrating the financial systems and operations of the two companies. Laurie also held executive positions at Sony Metreon, The North Face, and various high-tech companies. Laurie earned her Bachelor of Science Degree with major in accounting from San Francisco State University. She was also a California Certified Public Accountant.